Zafirlukast Tablet, Film Coated
Product Images NDC 59651-291

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zafirlukast (NDC 59651-291). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Zafirlukast Fig1)

A line graph showing mean beta-2 agonist use (puffs per day) over trial weeks for three groups: placebo, zafirlukast 20 mg twice daily, and cromolyn sodium 1600 mcg four times a day. The y-axis measures adjusted treatment means of puffs/day, and the x-axis represents trial weeks from 0 to 14.*

FDA Label Image

Package Label-principal Display Panel (10 mg)

Label for Zafirlukast Tablets 10 mg film-coated tablets by Aurobindo Pharma Limited. The label states dispensing instructions, storage conditions, and includes distributor information for Aurobindo Pharma USA, Inc. It also shows a package count of 60 tablets and the NDC 59651-291-60.*

FDA Label Image

Package Label-principal Display Panel (20 mg)

Label for Zafirlukast Tablets 20 mg film-coated tablets, with a quantity of 60 tablets. The label includes the National Drug Code (NDC) 59651-292-60, storage instructions at 20 to 25°C, and a warning to keep out of reach of children. The product is distributed by Aurobindo Pharma USA, Inc. and made in India by Aurobindo Pharma Limited.*

FDA Label Image

Chemical-structure (Zafirlukast Str)

Chemical structure diagram of the active ingredient zafirlukast, showing its molecular framework with various functional groups arranged in a complex organic structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.